AbbVie Inc. (FRA:4AB)
Germany · Delayed Price · Currency is EUR 183.60
-0.60 (-0.33%)
At close: Jan 30, 2026
AbbVie Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 2,388 | 4,278 | 4,863 | 11,836 | 11,542 | 4,616 |
Depreciation & Amortization | 8,254 | 8,386 | 8,698 | 8,467 | 8,521 | 6,471 |
Loss (Gain) From Sale of Assets | - | - | - | -172 | -68 | - |
Asset Writedown & Restructuring Costs | 10,648 | 7,233 | 5,007 | 1,467 | 1,174 | 1,376 |
Stock-Based Compensation | 962 | 911 | 747 | 671 | 692 | 753 |
Other Operating Activities | 894 | 780 | 711 | 2,768 | 2,147 | 4,266 |
Change in Accounts Receivable | -1,265 | 207 | 66 | -1,455 | -1,321 | -929 |
Change in Inventory | -337 | -319 | -417 | -686 | -142 | -40 |
Change in Accounts Payable | 2,796 | 177 | 3,840 | 1,769 | 1,719 | 1,514 |
Change in Other Net Operating Assets | -269 | 361 | -188 | -264 | -197 | 134 |
Operating Cash Flow | 20,860 | 18,806 | 22,839 | 24,943 | 22,777 | 17,588 |
Operating Cash Flow Growth | 26.34% | -17.66% | -8.43% | 9.51% | 29.50% | 32.00% |
Capital Expenditures | -1,176 | -974 | -777 | -695 | -787 | -798 |
Cash Acquisitions | -6,072 | -20,517 | -1,223 | -794 | -1,902 | -39,610 |
Investment in Securities | 25 | 482 | -22 | 92 | -21 | 1,464 |
Other Investing Activities | 169 | 189 | 13 | 774 | 366 | 1,387 |
Investing Cash Flow | -7,054 | -20,820 | -2,009 | -623 | -2,344 | -37,557 |
Short-Term Debt Issued | - | 5,008 | - | - | - | - |
Long-Term Debt Issued | - | 16,963 | - | 2,000 | 1,000 | 3,000 |
Total Debt Issued | 11,791 | 21,971 | - | 2,000 | 1,000 | 3,000 |
Short-Term Debt Repaid | - | -5,008 | - | - | - | - |
Long-Term Debt Repaid | - | -9,613 | -4,149 | -14,433 | -9,414 | -5,683 |
Total Debt Repaid | -14,558 | -14,621 | -4,149 | -14,433 | -9,414 | -5,683 |
Net Debt Issued (Repaid) | -2,767 | 7,350 | -4,149 | -12,433 | -8,414 | -2,683 |
Issuance of Common Stock | 134 | 214 | 180 | 262 | 244 | 209 |
Repurchase of Common Stock | -1,335 | -1,708 | -1,972 | -1,487 | -934 | -978 |
Common Dividends Paid | -11,498 | -11,025 | -10,539 | -10,043 | -9,261 | -7,716 |
Other Financing Activities | 47 | -42 | -742 | -1,102 | -674 | -333 |
Financing Cash Flow | -15,419 | -5,211 | -17,222 | -24,803 | -19,039 | -11,501 |
Foreign Exchange Rate Adjustments | -15 | -65 | 5 | -62 | -97 | -5 |
Net Cash Flow | -1,628 | -7,290 | 3,613 | -545 | 1,297 | -31,475 |
Free Cash Flow | 19,684 | 17,832 | 22,062 | 24,248 | 21,990 | 16,790 |
Free Cash Flow Growth | 25.99% | -19.17% | -9.01% | 10.27% | 30.97% | 31.46% |
Free Cash Flow Margin | 33.00% | 31.65% | 40.62% | 41.77% | 39.13% | 36.66% |
Free Cash Flow Per Share | 11.10 | 10.06 | 12.44 | 13.64 | 12.38 | 10.04 |
Cash Interest Paid | 2,811 | 2,811 | 2,469 | 2,546 | 2,712 | 2,619 |
Cash Income Tax Paid | 4,064 | 4,064 | 4,702 | 2,988 | 3,648 | 1,674 |
Levered Free Cash Flow | 20,799 | 19,978 | 22,629 | 21,261 | 19,394 | 16,222 |
Unlevered Free Cash Flow | 22,600 | 21,733 | 24,019 | 22,655 | 20,908 | 17,756 |
Change in Working Capital | -2,286 | -2,782 | 2,813 | -94 | -1,231 | 106 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.